Nimbus joins AWS's elite Building with Llama program

This title was summarized by AI from the post below.

We're pleased to announce that Nimbus has been selected for AWS's elite Building with Llama program, one of 30 companies chosen from over 1,000 applicants! This program provides access to advanced AI models from Meta, running on AWS infrastructure, to accelerate our drug discovery efforts. We’re fine-tuning these tools to enhance our chemistry-aware AI infrastructure to help our scientists explore chemical space more efficiently, including predicting molecular properties, assessing drug-like characteristics, evaluating synthetic routes, and analyzing compound-target interactions. Our thanks to AWS Startups, Meta for Developers, and Azadeh Yazdan for this opportunity, and congratulations to our fellow program participants.

  • No alternative text description for this image
Abbas Kazimi

Chief Executive Officer at Nimbus Therapeutics | Board Member

4w

Well done Daniel Price, Leela Sriram Dodda, James Carter, Matthew Medina & the whole team! Pushing drug discovery bounds further to impact the medicines we design 💪🏼🙏🏼!

Adil Ashary

Materials Engineering, Fuel Cell, Coatings: Thermal Spray, EBPVD and Diffusion, Corrosion, High Temperature

4w

Congratulations Abbas Kazmi and the team for this great achievement, and thank you developing drugs using the most advanced technologies.

Ben Davis

Head of Business Development - Technium, the connectivity company

4w

Amazing, team!

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories